Peter B. Bitterman - Publications

Affiliations: 
Microbiology, Immunology and Cancer Biology University of Minnesota, Twin Cities, Minneapolis, MN 
Area:
Bioinformatics Biology, Genetics

40 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any innacuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2019 Sandri BJ, Masvidal L, Murie C, Bartish M, Avdulov S, Higgins L, Markowski T, Peterson M, Bergh J, Yang P, Rolny C, Limper AH, Griffin TJ, Bitterman PB, Wendt CH, et al. Distinct Cancer-Promoting Stromal Gene Expression Depending on Lung Function. American Journal of Respiratory and Critical Care Medicine. PMID 30742544 DOI: 10.1164/rccm.201801-0080OC  0.48
2018 Wendt CH, Sandri BJ, Masvidal L, Murie C, Bartish M, Avdulov S, Higgins L, Markowski T, Peterson M, Bergh J, Yang P, Rolny C, Limper AH, Griffin TJ, Bitterman PB, et al. Chronic Obstructive Pulmonary Disease Phenotype Dictates Cancer-Promoting Stromal Gene Expression Programs. Annals of the American Thoracic Society. 15: S290-S291. PMID 30759015 DOI: 10.1513/AnnalsATS.201806-421MG  0.48
2018 De A, Jacobson BA, Peterson MS, Stelzner ME, Jay-Dixon J, Kratzke MG, Patel MR, Bitterman PB, Kratzke RA. Inhibition of oncogenic cap-dependent translation by 4EGI-1 reduces growth, enhances chemosensitivity and alters genome-wide translation in non-small cell lung cancer. Cancer Gene Therapy. PMID 30420719 DOI: 10.1038/s41417-018-0058-6  0.32
2016 Ochnik AM, Peterson MS, Avdulov SV, Oh AS, Bitterman PB, Yee D. Amplified in Breast Cancer Regulates Transcription and Translation in Breast Cancer Cells. Neoplasia (New York, N.Y.). 18: 100-10. PMID 26936396 DOI: 10.1016/j.neo.2016.01.001  0.32
2015 Khalil W, Xia H, Bodempudi V, Kahm J, Hergert P, Smith K, Peterson M, Parker M, Herrera J, Bitterman PB, Henke CA. Pathologic Regulation of Collagen I by an Aberrant PP2A/HDAC4/miR-29 Signal Axis in IPF Fibroblasts. American Journal of Respiratory Cell and Molecular Biology. PMID 25612003 DOI: 10.1165/rcmb.2014-0150OC  0.32
2015 Avdulov S, Herrera J, Smith K, Peterson M, Gomez-Garcia JR, Beadnell TC, Schwertfeger KL, Benyumov AO, Manivel JC, Li S, Bielinsky AK, Yee D, Bitterman PB, Polunovsky VA. eIF4E threshold levels differ in governing normal and neoplastic expansion of mammary stem and luminal progenitor cells. Cancer Research. 75: 687-97. PMID 25524901 DOI: 10.1158/0008-5472.CAN-14-2571  0.32
2015 Bitterman PB, Polunovsky VA. eIF4E-mediated translational control of cancer incidence. Biochimica Et Biophysica Acta. 1849: 774-80. PMID 25263391 DOI: 10.1016/j.bbagrm.2014.09.007  0.32
2014 Bhargava M, Becker TL, Viken KJ, Jagtap PD, Dey S, Steinbach MS, Wu B, Kumar V, Bitterman PB, Ingbar DH, Wendt CH. Proteomic profiles in acute respiratory distress syndrome differentiates survivors from non-survivors. Plos One. 9: e109713. PMID 25290099 DOI: 10.1371/journal.pone.0109713  0.32
2014 Bodempudi V, Hergert P, Smith K, Xia H, Herrera J, Peterson M, Khalil W, Kahm J, Bitterman PB, Henke CA. miR-210 promotes IPF fibroblast proliferation in response to hypoxia. American Journal of Physiology. Lung Cellular and Molecular Physiology. 307: L283-94. PMID 24951777 DOI: 10.1152/ajplung.00069.2014  0.32
2014 Chen EZ, Jacobson BA, Patel MR, Okon AM, Li S, Xiong K, Vaidya AJ, Bitterman PB, Wagner CR, Kratzke RA. Small-molecule inhibition of oncogenic eukaryotic protein translation in mesothelioma cells. Investigational New Drugs. 32: 598-603. PMID 24711125 DOI: 10.1007/s10637-014-0076-7  0.32
2014 Hohberger LA, Schroeder DR, Bartholmai BJ, Yang P, Wendt CH, Bitterman PB, Larsson O, Limper AH. Correlation of regional emphysema and lung cancer: a lung tissue research consortium-based study. Journal of Thoracic Oncology : Official Publication of the International Association For the Study of Lung Cancer. 9: 639-45. PMID 24662456 DOI: 10.1097/JTO.0000000000000144  0.32
2014 Xia H, Bodempudi V, Benyumov A, Hergert P, Tank D, Herrera J, Braziunas J, Larsson O, Parker M, Rossi D, Smith K, Peterson M, Limper A, Jessurun J, Connett J, ... ... Bitterman PB, et al. Identification of a cell-of-origin for fibroblasts comprising the fibrotic reticulum in idiopathic pulmonary fibrosis. The American Journal of Pathology. 184: 1369-83. PMID 24631025 DOI: 10.1016/j.ajpath.2014.01.012  0.32
2014 Parker MW, Rossi D, Peterson M, Smith K, Sikström K, White ES, Connett JE, Henke CA, Larsson O, Bitterman PB. Fibrotic extracellular matrix activates a profibrotic positive feedback loop. The Journal of Clinical Investigation. 124: 1622-35. PMID 24590289 DOI: 10.1172/JCI71386  0.32
2013 Bhargava M, Dey S, Becker T, Steinbach M, Wu B, Lee SM, Higgins L, Kumar V, Bitterman PB, Ingbar DH, Wendt CH. Protein expression profile of rat type two alveolar epithelial cells during hyperoxic stress and recovery. American Journal of Physiology. Lung Cellular and Molecular Physiology. 305: L604-14. PMID 24014686 DOI: 10.1152/ajplung.00079.2013  0.32
2013 Li S, Jia Y, Jacobson B, McCauley J, Kratzke R, Bitterman PB, Wagner CR. Treatment of breast and lung cancer cells with a N-7 benzyl guanosine monophosphate tryptamine phosphoramidate pronucleotide (4Ei-1) results in chemosensitization to gemcitabine and induced eIF4E proteasomal degradation. Molecular Pharmaceutics. 10: 523-31. PMID 23289910 DOI: 10.1021/mp300699d  0.32
2012 Bitterman PB, Polunovsky VA. Attacking a nexus of the oncogenic circuitry by reversing aberrant eIF4F-mediated translation. Molecular Cancer Therapeutics. 11: 1051-61. PMID 22572598 DOI: 10.1158/1535-7163.MCT-11-0530  0.32
2012 Jia Y, Polunovsky V, Bitterman PB, Wagner CR. Cap-dependent translation initiation factor eIF4E: an emerging anticancer drug target. Medicinal Research Reviews. 32: 786-814. PMID 22495651 DOI: 10.1002/med.21260  0.32
2012 Bitterman PB, Polunovsky VA. Translational control of cell fate: from integration of environmental signals to breaching anticancer defense. Cell Cycle (Georgetown, Tex.). 11: 1097-107. PMID 22356766 DOI: 10.4161/cc.11.6.19610  0.32
2012 Patel MR, Sadiq AA, Jay-Dixon J, Jirakulaporn T, Jacobson BA, Farassati F, Bitterman PB, Kratzke RA. Novel role of c-jun N-terminal kinase in regulating the initiation of cap-dependent translation. International Journal of Oncology. 40: 577-82. PMID 22076560 DOI: 10.3892/ijo.2011.1252  0.32
2011 Borok Z, Whitsett JA, Bitterman PB, Thannickal VJ, Kotton DN, Reynolds SD, Krasnow MA, Bianchi DW, Morrisey EE, Hogan BL, Kurie JM, Walker DC, Radisky DC, Nishimura SL, Violette SM, et al. Cell plasticity in lung injury and repair: report from an NHLBI workshop, April 19-20, 2010. Proceedings of the American Thoracic Society. 8: 215-22. PMID 21653526 DOI: 10.1513/pats.201012-067CB  0.32
2011 Zu T, Gibbens B, Doty NS, Gomes-Pereira M, Huguet A, Stone MD, Margolis J, Peterson M, Markowski TW, Ingram MA, Nan Z, Forster C, Low WC, Schoser B, Somia NV, ... ... Bitterman PB, et al. Non-ATG-initiated translation directed by microsatellite expansions. Proceedings of the National Academy of Sciences of the United States of America. 108: 260-5. PMID 21173221 DOI: 10.1073/pnas.1013343108  0.32
2010 Jia Y, Chiu TL, Amin EA, Polunovsky V, Bitterman PB, Wagner CR. Design, synthesis and evaluation of analogs of initiation factor 4E (eIF4E) cap-binding antagonist Bn7-GMP. European Journal of Medicinal Chemistry. 45: 1304-13. PMID 20060622 DOI: 10.1016/j.ejmech.2009.11.054  0.32
2009 Kim YY, Von Weymarn L, Larsson O, Fan D, Underwood JM, Peterson MS, Hecht SS, Polunovsky VA, Bitterman PB. Eukaryotic initiation factor 4E binding protein family of proteins: sentinels at a translational control checkpoint in lung tumor defense. Cancer Research. 69: 8455-62. PMID 19843855 DOI: 10.1158/0008-5472.CAN-09-1923  0.32
2009 Jacobson BA, De A, Kratzke MG, Patel MR, Jay-Dixon J, Whitson BA, Sadiq AA, Bitterman PB, Polunovsky VA, Kratzke RA. Activated 4E-BP1 represses tumourigenesis and IGF-I-mediated activation of the eIF4F complex in mesothelioma. British Journal of Cancer. 101: 424-31. PMID 19603014 DOI: 10.1038/sj.bjc.6605184  0.32
2009 Fan D, Bitterman PB, Larsson O. Regulatory element identification in subsets of transcripts: comparison and integration of current computational methods. Rna (New York, N.Y.). 15: 1469-82. PMID 19553345 DOI: 10.1261/rna.1617009  0.48
2009 Ghosh B, Benyumov AO, Ghosh P, Jia Y, Avdulov S, Dahlberg PS, Peterson M, Smith K, Polunovsky VA, Bitterman PB, Wagner CR. Nontoxic chemical interdiction of the epithelial-to-mesenchymal transition by targeting cap-dependent translation. Acs Chemical Biology. 4: 367-77. PMID 19351181 DOI: 10.1021/cb9000475  0.32
2008 Larsson O, Diebold D, Fan D, Peterson M, Nho RS, Bitterman PB, Henke CA. Fibrotic myofibroblasts manifest genome-wide derangements of translational control. Plos One. 3: e3220. PMID 18795102 DOI: 10.1371/journal.pone.0003220  0.48
2008 Ghosh P, Cheng J, Chou TF, Jia Y, Avdulov S, Bitterman PB, Polunovsky VA, Wagner CR. Expression, purification and characterization of recombinant mouse translation initiation factor eIF4E as a dihydrofolate reductase (DHFR) fusion protein. Protein Expression and Purification. 60: 132-9. PMID 18479935 DOI: 10.1016/j.pep.2008.03.024  0.32
2008 Vlasova IA, Tahoe NM, Fan D, Larsson O, Rattenbacher B, Sternjohn JR, Vasdewani J, Karypis G, Reilly CS, Bitterman PB, Bohjanen PR. Conserved GU-rich elements mediate mRNA decay by binding to CUG-binding protein 1. Molecular Cell. 29: 263-70. PMID 18243120 DOI: 10.1016/j.molcel.2007.11.024  0.32
2007 Larsson O, Li S, Issaenko OA, Avdulov S, Peterson M, Smith K, Bitterman PB, Polunovsky VA. Eukaryotic translation initiation factor 4E-induced progression of primary human mammary epithelial cells along the cancer pathway is associated with targeted translational deregulation of oncogenic drivers and inhibitors Cancer Research. 67: 6814-6824. PMID 17638893 DOI: 10.1158/0008-5472.CAN-07-0752  0.32
2007 Mullany LK, Nelsen CJ, Hanse EA, Goggin MM, Anttila CK, Peterson M, Bitterman PB, Raghavan A, Crary GS, Albrecht JH. Akt-mediated liver growth promotes induction of cyclin E through a novel translational mechanism and a p21-mediated cell cycle arrest. The Journal of Biological Chemistry. 282: 21244-52. PMID 17517888 DOI: 10.1074/jbc.M702110200  0.32
2006 Polunovsky VA, Bitterman PB. The cap-dependent translation apparatus integrates and amplifies cancer pathways. Rna Biology. 3: 10-7. PMID 17114939  0.32
2006 Larsson O, Perlman DM, Fan D, Reilly CS, Peterson M, Dahlgren C, Liang Z, Li S, Polunovsky VA, Wahlestedt C, Bitterman PB. Apoptosis resistance downstream of eIF4E: posttranscriptional activation of an anti-apoptotic transcript carrying a consensus hairpin structure. Nucleic Acids Research. 34: 4375-86. PMID 16936314 DOI: 10.1093/nar/gkl558  0.32
2006 Jacobson BA, Alter MD, Kratzke MG, Frizelle SP, Zhang Y, Peterson MS, Avdulov S, Mohorn RP, Whitson BA, Bitterman PB, Polunovsky VA, Kratzke RA. Repression of cap-dependent translation attenuates the transformed phenotype in non-small cell lung cancer both in vitro and in vivo. Cancer Research. 66: 4256-62. PMID 16618749 DOI: 10.1158/0008-5472.CAN-05-2879  0.32
2005 Ghosh P, Park C, Peterson MS, Bitterman PB, Polunovsky VA, Wagner CR. Synthesis and evaluation of potential inhibitors of eIF4E cap binding to 7-methyl GTP. Bioorganic & Medicinal Chemistry Letters. 15: 2177-80. PMID 15808492 DOI: 10.1016/j.bmcl.2005.01.080  0.32
2004 Avdulov S, Li S, Michalek V, Burrichter D, Peterson M, Perlman DM, Manivel JC, Sonenberg N, Yee D, Bitterman PB, Polunovsky VA. Activation of translation complex eIF4F is essential for the genesis and maintenance of the malignant phenotype in human mammary epithelial cells. Cancer Cell. 5: 553-63. PMID 15193258 DOI: 10.1016/j.ccr.2004.05.024  0.32
2004 Li S, Perlman DM, Peterson MS, Burrichter D, Avdulov S, Polunovsky VA, Bitterman PB. Translation initiation factor 4E blocks endoplasmic reticulum-mediated apoptosis. The Journal of Biological Chemistry. 279: 21312-7. PMID 14990584 DOI: 10.1074/jbc.M312467200  0.32
2003 Li S, Takasu T, Perlman DM, Peterson MS, Burrichter D, Avdulov S, Bitterman PB, Polunovsky VA. Translation factor eIF4E rescues cells from Myc-dependent apoptosis by inhibiting cytochrome c release. The Journal of Biological Chemistry. 278: 3015-22. PMID 12441348 DOI: 10.1074/jbc.M208821200  0.32
2002 Crystal RG, Bitterman PB, Mossman B, Schwarz MI, Sheppard D, Almasy L, Chapman HA, Friedman SL, King TE, Leinwand LA, Liotta L, Martin GR, Schwartz DA, Schultz GS, Wagner CR, et al. Future research directions in idiopathic pulmonary fibrosis: summary of a National Heart, Lung, and Blood Institute working group. American Journal of Respiratory and Critical Care Medicine. 166: 236-46. PMID 12119236 DOI: 10.1164/rccm.2201069  0.32
2002 Li S, Sonenberg N, Gingras AC, Peterson M, Avdulov S, Polunovsky VA, Bitterman PB. Translational control of cell fate: availability of phosphorylation sites on translational repressor 4E-BP1 governs its proapoptotic potency. Molecular and Cellular Biology. 22: 2853-61. PMID 11909977 DOI: 10.1128/MCB.22.8.2853-2861.2002  0.32
Show low-probability matches.